Jan 8 |
ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea
|
Dec 19 |
Why Compugen Shares Are Trading Higher By Over 200%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
|
Dec 19 |
ProSomnus Treatment for Sleep Apnea Effective, Study Shows
|
Dec 19 |
Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices
|
Dec 12 |
ProSomnus CEO Len Liptak unveils game-changing device and promising clinical trial results for 2024
|
Nov 30 |
Why Salesforce Shares Are Trading Higher By Over 9%; Here Are 20 Stocks Moving Premarket
|
Nov 9 |
ProSomnus GAAP EPS of -$0.70 misses by $0.36, revenue of $7.1M beats by $0.07M
|
Nov 9 |
ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results
|